Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients
- PMID: 17576788
- PMCID: PMC1955109
- DOI: 10.1136/ard.2006.058784
Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients
Erratum in
- Ann Rheum Dis. 2007 Aug;66(8):1128
References
-
- Doria A, Iaccarino L, Sarzi‐Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 200514683–686. - PubMed
-
- D'Cruz D, Khamashta M, Hughes G R V. Cardiovascular manifestations of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. Philadelphia: Lippincott Williams &Wilkins, 2001645
-
- Houssiau F A, Vasconcelos C, D'Cruz D, Sebastiani G D, de Ramon Garrido E, Danieli M G.et al Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial. Arthritis Rheum 2004503934–3940. - PubMed
-
- Sherer Y, Shoenfeld Y. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus. Autoimmun Rev 20065153–155. - PubMed
-
- Sherer Y, Levy Y. Shoenfeld Y. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 199918238–240. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
